Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Cell
|
| gptkbp:ATCCNumber |
CCL-131
|
| gptkbp:cellType |
gptkb:neuroblastoma
|
| gptkbp:differentiationInducedBy |
retinoic acid
|
| gptkbp:doublingTime |
~20 hours
|
| gptkbp:expressedIn |
neuronal markers
|
| gptkbp:fullName |
Neuro-2a
|
| gptkbp:growthMedium |
MEM (Minimum Essential Medium)
|
| gptkbp:growthSupplement |
10% fetal bovine serum
|
| https://www.w3.org/2000/01/rdf-schema#label |
N2A
|
| gptkbp:morphologicalType |
adherent
|
| gptkbp:organism |
gptkb:Mus_musculus
|
| gptkbp:origin |
mouse brain
|
| gptkbp:repository |
gptkb:ATCC
gptkb:DSMZ |
| gptkbp:species |
gptkb:mouse
|
| gptkbp:transfection |
highly transfectable
|
| gptkbp:usedFor |
drug screening
neuronal differentiation studies |
| gptkbp:usedIn |
cancer research
neuroscience research |
| gptkbp:bfsParent |
gptkb:GZ-20
gptkb:Wingfoot_Two |
| gptkbp:bfsLayer |
7
|